-
Investor Spotlight on BioSante Pharmaceuticals (NASDAQ: BPAX) Lead Product LibiGel® - testosterone gel for the treatment of female sexual dysfunction
Wednesday, November 10, 2010 - 2:01pm | 1739Read More...Point Roberts, WA, LINCOLNSHIRE, Ill - November 9, 2010 (Investorideas.com Newswire) Investor ideas and its biotech portal present a company and product spotlight for B ioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) lead product LibiGel®. Join Investor Ideas Members to access the Renewable Energy...
-
Biotech/Pharma Stocks News; UV Flu Technologies (OTCBB: UVFT) ViraTech UV-400 Featured This Weekend on Nationally Televised Designing Spaces "Holiday Spaces" Show
Wednesday, November 10, 2010 - 11:28am | 839Read More...CENTERVILLE, MA � November 10, 2010 (Investorideas.com Newswire) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that the Company's ViraTech UV-400 air purifier technology is featured during "Designing Spaces-Innovations for a Healthy Home this Holiday Season,"...
-
Biotech/Pharma Stocks News; UV Flu Technologies (OTCBB: UVFT) Commences Shipments of UV-400 Bacteria Killing Air Purifier to Europe
Monday, November 8, 2010 - 11:14am | 800Read More...CENTERVILLE, MA � November 8, 2010 (Investorideas.com Newswire) - UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is pleased to announce that shipments of its ViraTech UV-400 Air Purifier to its new European distributor Societe' Nema Citizen of Paris, France have commenced. Join Investor...
-
NASDAQ Biotech/Pharma Market Leaders; (NASDAQ:BPAX), (NASDAQ:AMGN), (NASDAQ:LIFE) Stocks to Follow for Wednesday
Wednesday, November 3, 2010 - 3:29pm | 993Read More...Visit this company: www.biosantepharma.com Point Roberts, WA - November 3, 2010 (Investorideas.com Newswire and www.biotechindustrystocks.com) - InvestorIdeas.com, a leader in sector research tools for investors, features a Biotech /Pharma Sector Snapshot featuring some of the NASDAQ�s Actively...
-
Pharma To Benefit From New Healthcare Bill
Monday, March 22, 2010 - 12:21pm | 143Read More...The US government is now in charge of healthcare, following a 219 to 212 vote in favor of the reform. The post-vote environment is likely to benefit pharma stocks in the near term, according to Asia Pacific Markets. The vote, however, is bad news for generics, since it includes a "12-year data...

